4.
Effective Intake: Are there sufficient data from adequate clinical trials and dietary intervention studies to allow for the determination of the minimum intake amount necessary to achieve a population-based health benefit?
5.
Background Dietary Intake: How much of the substance or food constituent are people currently consuming?
6.
Mechanisms of Actions by which the substance or food constituent exert their health benefits known and comprehensively understood?
7.
Safety Are there adequate data to demonstrate the general safety of the substance or food constituent?
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Use to assess new studies and data
What is Cocoa ? 
Complex Composition
The complexity of different polyphenol classes, and even within a class such as cocoa flavanols & procyanidins, highlights:
• the challenge of developing robust analytical techniques to fully characterise natural polyphenol sources,
• the importance of studies using human subjects and the related high costs for such research, and
• the potential for "attractive simplifications" in communication to lead to public perceptions that may not be supported by the science.
Hence the epidemiological data that shapes many perceptions , and simple hypotheses (eg antioxidants and heart health) are often not supported by well designed human intervention studies 
% Procyanidin Remaining

Days of Fermentation
What must be considered to move from talking about cocoa flavanols as something good, to being an important part of our diet?
• Consistent Terminology: The need for general improvements and consensus with regard to the practical use of the terms 'flavanols' and 'procyanidins' as well as the standardization of analytical methods and definitions -eg COCOA FLAVANOLS
• Scientific Rigour & Standards: The need for general improvements of the standards and scientific rigor applied in the context of clinical dietary intervention studies and epidemiological investigations , and the interpretation of results
• Plausible Mechanisms of Action: The need for identifying pharmacological targets and the mechanisms of action by which flavanols and procyanidins mediate their biological effects in vivo ( Actually well progressed for endothelial function and BP)
• Population Intake data: The need for more comprehensive information on the population-based intake of dietary flavanols and procyanidins, as well as on safety in the specific contexts of public health and medical practice if the test compound is a food constituent, the effect mediated by the pure, and chemically identified food constituent should closely mimic physiological effects; the withholding, (or reduction in intake), of foods containing the test compound, or the withholding of the test compound itself, should be consistent with a reversal or an attenuation of the observed effect; and the inhibition of endogenous mediator pathways, hypothesized to be causally linked to the effect exerted by the test compound, should result in an attenuation of such effects. Nevertheless, it is important to acknowledge that despite the progress made, serious gaps and shortfalls with regard to available data and overall understanding continue to exist. In order to provide final and conclusive data on the health benefits of dietary flavanols and procyanidins in the context of public health or clinical practice it will be essential to identify and to address those gaps and shortfalls. The four most crucial issues include:
• The need for general improvements and consensus with regard to the practical use of the terms 'flavanols' and 'procyanidins' as well as the standardization of analytical methods and definitions
• The need for general improvements of the standards and scientific rigor applied in the context of clinical dietary intervention studies and epidemiological investigations
• The need for identifying pharmacological targets and the mechanisms of action by which flavanols and procyanidins mediate their biological effects in vivo
• The need for more comprehensive information on the population-based intake of dietary flavanols and procyanidins [considering geographic, ethnic, and socioeconomic, and health status differences], as well as on safety in the specific contexts of public health and medical practice • Scientists have found that consuming cocoa flavanols -naturally occurring compounds in cocoa -may offer a benefit to those affected by type 2 diabetes.
• Consuming a cocoa flavanol-rich beverage daily may have the potential to positively impact the blood vessel dysfunction associated with diabetes, suggests a first-of-its-kind study recently published in the Journal of the American College of Cardiology by an international group of scientists.
• Study participants who regularly consumed a cocoa flavanol-rich beverage made using the Mars, Incorporated Cocoapro® process experienced a 30 percent improvement in measured vessel function at the completion of a 30-day trial
